PubRank

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Clinical Trial ID NCT01840579

PubWeight™ 15.95‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01840579

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer 2014 1.35
2 Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res 2014 1.24
3 Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology 2014 1.22
4 Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer. Sci Rep 2015 1.18
5 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
6 The evolving genomic classification of lung cancer. J Pathol 2014 1.08
7 Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol 2015 0.97
8 Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015 0.92
9 Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". Toxins (Basel) 2014 0.92
10 Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer? Semin Oncol 2013 0.87
11 Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors. Invest New Drugs 2016 0.82
12 PD-1 and PD-L1 antibodies for melanoma. Hum Vaccin Immunother 2014 0.80
13 Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy. Med Oncol 2014 0.80
14 Cancer stem cells and immunoresistance: clinical implications and solutions. Transl Lung Cancer Res 2015 0.79
15 Immune checkpoint blockade therapy for bladder cancer treatment. Investig Clin Urol 2016 0.78
16 Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date. Onco Targets Ther 2016 0.75
17 Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection. Hepat Mon 2016 0.75
Next 100